Complement deficiencies and systemic lupus erythematosus

References

• Figueroa JE, Densen P. Infectious diseases associated with complement deficiencies. Clin Microbiol Rev 1991; 4(3)359–395
   PubMed Web of Science ®Google Scholar
• Jönsson G, Truedsson L, Oxelius V, Sturfelt G, Braconier JH, Sjöholm AG. Homozygous C2 deficiency in Sweden: Frequent occurrence of invasive infection, atherosclerosis and rheumatic disease. Medicine (Baltimore) 2005; 84(1)23–34
   Google Scholar
• Ochs HD, Nonoyama S, Zhu Q, Farrington M, Wedgwood RJ. Regulation of antibody responses: The role of complement and adhesion molecules. Clin Immunol Immunopathol 1993; 67(3 Pt2)S33–S40
   Google Scholar
• Pickering MC, Botto M, Taylor PR, Lachmann PJ, Walport MJ. Systemic lupus erythematosus, complement deficiency and apoptosis. Adv Immunol 2000; 76: 227–324
   PubMed Web of Science ®Google Scholar
• Rugonfalvi-Kiss S, Endresz V, Madsen HO, Burian K, Duba J, Prohaszka Z, et al. Association of Chlamydia pneumoniae with coronary artery disease and its progression is dependent on the modifying effect of mannose-binding lectin. Circulation 2002; 106(9)1071–1076
   Google Scholar
• Brown EJ, Hosea SW, Frank MM. The role of antibody and complement in the reticuloendothelial clearance of pneumococci from the bloodstream. Rev Infect Dis 1983; 5(Suppl 4)S797–S805
   Google Scholar
• Brown JS, Hussell T, Gilliland SM, Holden DW, Paton JC, Ehrenstein MR, et al. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc Natl Acad Sci (USA) 2002; 99(26)16969–16974
   Google Scholar
• Buono C, Come CE, Witztum JL, Maguire GF, Connelly PW, Carroll M, et al. Influence of C3 deficiency on atherosclerosis. Circulation 2002; 105(25)3025–3031
   PubMed Web of Science ®Google Scholar
• Mitchell DA, Pickering MC, Warren J, Fossati-Jimack L, Cortes-Hernandez J, Cook HT, et al. C1q deficiency and autoimmunity: The effects of genetic background on disease expression. J Immunol 2002; 168(5)2538–2543
   PubMedGoogle Scholar
• Carroll MC. A protective role for innate immunity in systemic lupus erythematosus. Nat Rev Immunol 2004; 4(10)825–831
   Google Scholar
• Walport MJ. Complement. First of two parts. NJEM 2001; 344(14)1058–1066
   PubMed Web of Science ®Google Scholar
• Hourcade DE. The role of properdin in the assembly of the alternative pathway C3 convertases of complement. J Biol Chem 2006; 281(4)2128–2132
   PubMed Web of Science ®Google Scholar
• Pillemer L. The properdin system. Trans NY Acad Sci 1955; 17(7)526–530
   Google Scholar
• Medzhitov R, Janeway C, Jr. Innate immunity. NJEM 2000; 343(5)338–344
   PubMed Web of Science ®Google Scholar
• Sjöholm AG, Jönsson G, Braconier JH, Sturfelt G, Truedsson L. Complement deficiency and disease: An update. Mol Immunol 2006; 43(1–2)78–85
   Google Scholar
• Fijen CA, van den Bogaard R, Schipper M, Mannens M, Schlesinger M, Nordin FG, et al. Properdin deficiency: Molecular basis and disease association. Mol Immunol 1999; 36(13–14)863–867
   Google Scholar
• Zipfel PF, Heinen S, Jozsi M, Skerka C. Complement and diseases: Defective alternative pathway control results in kidney and eye diseases. Mol Immunol 2006; 43(1–2)97–106
   Google Scholar
• Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005; 308(5720)385–389
   PubMed Web of Science ®Google Scholar
• Manderson AP, Botto M, Walport MJ. The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol 2004; 22: 431–456
   PubMed Web of Science ®Google Scholar
• Jonsen A, Gunnarsson I, Gullstrand B, Svenungsson E, Bengtsson AA, Nived O, et al. Association between SLE nephritis and polymorphic variants of the CRP and FcgammaRIIIa genes. Rheumatology 2007, in press.
   Google Scholar
• Lipsker DM, Schreckenberg-Gilliot C, Uring-Lambert B, Meyer A, Hartmann D, Grosshans EM, et al. Lupus erythematosus associated with genetically determined deficiency of the second component of the complement. Arch Dermatol 2000; 136(12)1508–1514
   Google Scholar
• Yang Y, Chung EK, Zhou B, Lhotta K, Hebert LA, Birmingham DJ, et al. The intricate role of complement component C4 in human systemic lupus erythematosus. Curr Dir Autoimmun 2004; 7: 98–132
   PubMedGoogle Scholar
• Truedsson L, Sturfelt G, Johansen P, Nived O, Thuresson B. Sharing of MHC haplotypes among patients with systemic lupus erythematosus from unrelated Caucasian multicase families: Disease association with the extended haplotype [HLA, B8, SC01, DR17]. J Rheumatol 1995; 22(10)1852–1861
   Google Scholar
• Jönsen A, Bengtsson AA, Sturfelt G, Truedsson L. Analysis of HLA DR, HLA DQ, C4A, FcgammaRIIa, Fcgamma RIIIA, MBL and IL-1Ra allelic variants in Caucasian systemic lupus erythematosus patients suggests an effect of combined Fcgamma RIIa R/R andIL-1Ra 2/2 genotypes on disease susceptibility. Arthritis Res Ther 2004; 6(6)R557–R562
   Google Scholar
• Jönsson G, Sjöholm AG, Truedsson L, Bengtsson AA, Braconier JH, Sturfelt G. Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency Rheumatology 2007;46(7):1133–1139.
   Google Scholar
• Maddison PJ, ANA-negative SLE. Clin Rheum Dis 1982; 8(1)105–119
   Google Scholar
• Jönsen A, Gullstrand B, Güner N, Bengtsson AA, Nived O, Truedsson L, et al. Genetically determined mannan-binding lectin deficiency is of minor importance in determining susceptibility to severe infections and vascular organ damage in systemic lupus erythematosus. Lupus 2007; 16(3)1–9
   Google Scholar
• Garred P, Madsen HO, Halberg P, Petersen J, Kronborg G, Svejgaard A, et al. Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Artritis Rheum 1999; 42(10)2145–2152
   Google Scholar
• Garred P, Pressler T, Madsen HO, Frederiksen B, Svejgaard A, Hoiby N, et al. Association between mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest 1999; 104(4)431–437
   PubMedGoogle Scholar
• Carlsson M, Sjöholm AG, Eriksson L, Thiel S, Jensenius JC, Segelmark M, et al. Deficiency of the mannan-binding lectin pathway of complement and poor outcome in cyctic fibrosis: Bacterial colonization may be decisive for a relationship. Clin Exp Immunol 2005; 139(2)306–313
   PubMed Web of Science ®Google Scholar
• Troelsen LN, Garred P, Madsen HO, Jacobsen S. Genetically determined high serum levels of mannose-binding lectin and agalactosyl IgG are associated with ischemic heart disease in rheumatoid arthritis. Arthritis Rheum 2007; 56(1)21–29
   Google Scholar
• Best LG, Davidson M, North KE, MacCluer JW, Zhang Y, Lee ET, et al. Prospective analysis of mannose-binding lectin genotypes and coronary artery disease in American Indians: The strong heart study. Circulation 2004; 109(4)471–475
   Google Scholar
• Madsen HO, Videm V, Svejgaard A, Svennevig JL, Garred P. Association of mannose-binding lectin deficiency with severe atherosclerosis. Lancet 1998; 352(9132)959–960
   Google Scholar
• Ohlenschlaeger T, Garred P, Madsen HO, Jacobsen S. Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus. N Engl J Med 2004; 351(3)260–267
   Google Scholar
• Tsutsumi A, Takahashi R, Sumida T. Mannose binding lectin: Genetics and autoimmune disease. Autoimmun Rev 2005; 4(6)364–372
   PubMedGoogle Scholar
• Sturfelt G, Truedsson L. Complement and its breakdown products in SLE. Rheumatology (Oxford) 2005; 44(10)1227–1232
   Google Scholar
• Davies KA, Peters AM, Beynon HL, Walport MJ. Immune complex processing in patients with systemic lupus erythematosus in vivo imaging and clearance studies. J Clin Invest 1992; 90(5)2075–2083
   Google Scholar
• Iida K, Mornaghi R, Nussenzweig V. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus. J Exp Med 1982; 155(5)1427–1438
   Google Scholar
• Walport MJ, Ross GD, Mackworth-Young C, Watson JV, Hogg N, Lachmann PJ. Family studies of erythrocyte complement receptor type 1 levels: Reduced levels in patients with SLE are acquired, not inherited. Clin Exp Immunol 1985; 59(3)547–554
   Google Scholar
• Botto M. C1q knock-out mice for the study of complement deficiency in autoimmune disease. Exp Clin Immunogenet 1998; 15(4)231–234
   PubMedGoogle Scholar
• Botto M, Walport MJ. C1q, autoimmunity and apoptosis. Immunobiology 2002; 205(4–5)395–406
   PubMed Web of Science ®Google Scholar
• Taylor PR, Carugati A, Fadok VA, Cook HT, Andrews M, Carroll MC, et al. Hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med 2000; 192(3)359–366
   PubMed Web of Science ®Google Scholar
• Carroll MC. The role of complement in B-cell activation and tolerance. Adv Immunol 2000; 74: 61–88
   PubMedGoogle Scholar
• Yamada M, Oritani K, Kaisho T, Ishikawa J, Yoshida H, Takahashi I, et al. Complement C1q regulates LPD-induced cytokine production in bone marrow derived dendritic cells. Eur J Immunol 2004; 34(1)221–230
   Google Scholar
• Rönnblom L, Eloranta ML, Alm GV. Role of natural interferon-alpha producing cells (plasmacytoid dendritic cells) in autoimmunity. Autoimmunity 2003; 36(8)463–472
   PubMed Web of Science ®Google Scholar
• Pascual V, Farkas L, Banchereau J. Systemic lupus erythematosus: All roads lead to type I interferons. Curr Opin Immunol 2006; 18(6)676–682
   PubMed Web of Science ®Google Scholar
• Trouw LA, Roos A, Daha MR. Autoantibodies to complement components. Mol Immunol 2001; 38(2–3)199–206
   Google Scholar
• Trendelenburg M. Antibodies against C1q in patients with systemic lupus erythematosus. Springer Semin Immunopathol 2005; 27(3)276–285
   Google Scholar
• Tsacheva I, Radanova M, Todorova N, Argirova T, Kishore U. Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients. Mol Immunol 2007; 44(8)2157–2161
   Google Scholar
• Steinsson K, Erlendsson K, Valdimarsson H. Successful plasma infusion treatment of a patient with C2 deficiency and systemic lupus erythematosus: Clinical experience over forty-five months. Arthritis Rheum 1989; 32(7)906–913
   Google Scholar
• Sibilia J. Treatment of systemic lupus erythematosus in 2006. Joint Bone Spine 2006; 73(6)591–598
   Google Scholar